Literature DB >> 24920699

Open letter raises concerns about NICE guidance on statins.

Jacqui Wise1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24920699     DOI： 10.1136/bmj.g3937

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  9 in total

1.  Statin initiations and QRISK2 scoring in UK general practice: a THIN database study.

Authors:  Samuel Finnikin; Ronan Ryan; Tom Marshall
Journal:  Br J Gen Pract       Date:  2017-10-23       Impact factor: 5.386

2.  Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease.

Authors:  Ciaran N Kohli-Lynch; James Lewsey; Kathleen A Boyd; Dustin D French; Neil Jordan; Andrew E Moran; Naveed Sattar; David Preiss; Andrew H Briggs
Journal:  Circulation       Date:  2022-03-07       Impact factor: 39.918

3.  NHS health checks: an update on the debate and program implementation in England.

Authors:  Bayad Abdalrahman; Michael Soljak
Journal:  J Ambul Care Manage       Date:  2015 Jan-Mar

4.  Quantifying the contribution of statins to the decline in population mean cholesterol by socioeconomic group in England 1991 - 2012: a modelling study.

Authors:  Chris Kypridemos; Piotr Bandosz; Graeme L Hickey; Maria Guzman-Castillo; Kirk Allen; Iain Buchan; Simon Capewell; Martin O'Flaherty
Journal:  PLoS One       Date:  2015-04-09       Impact factor: 3.240

5.  Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol.

Authors:  Samuel Finnikin; Ronan Ryan; Tom Marshall
Journal:  BMJ Open       Date:  2016-11-17       Impact factor: 2.692

6.  The Economic Burden of Disease in France From the National Health Insurance Perspective: The Healthcare Expenditures and Conditions Mapping Used to Prepare the French Social Security Funding Act and the Public Health Act.

Authors:  Antoine Rachas; Christelle Gastaldi-Ménager; Pierre Denis; Pauline Barthélémy; Panayotis Constantinou; Jérôme Drouin; Dimitri Lastier; Thomas Lesuffleur; Corinne Mette; Muriel Nicolas; Laurence Pestel; Sébastien Rivière; Ayden Tajahmady; Claude Gissot; Anne Fagot-Campagna
Journal:  Med Care       Date:  2022-07-26       Impact factor: 3.178

7.  The Disparate Approaches of General Practitioners to the Pharmaceuticalisation of Cardiovascular Disease Prevention.

Authors:  Tom Douglass; Michael Calnan
Journal:  Front Sociol       Date:  2021-05-21

8.  Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population-Based Cohort Study.

Authors:  Maria Garcia-Gil; Marc Comas-Cufí; Jordi Blanch; Ruth Martí; Anna Ponjoan; Lia Alves-Cabratosa; Irene Petersen; Jaume Marrugat; Roberto Elosua; María Grau; Rafel Ramos
Journal:  Clin Pharmacol Ther       Date:  2018-02-02       Impact factor: 6.875

9.  Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care.

Authors:  Alexander Pate; Richard Emsley; Tjeerd van Staa
Journal:  Br J Gen Pract       Date:  2020-10-29       Impact factor: 5.386
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.